However, several studies have demonstrated that Rb1 has therapeutic potential against depression-like conditions and that it exerts an antidepressant-like effect against behavioral abnormalities caused by CSDS; however, its underlying mechanism is not fully understood. This evidence concerns the gene RB1 and depressive disorder.